National Science Day-2025 Special From NSD-2024 to NSD-2025: Journey of CSIR-CDRI was full of achievements, recognitions and contributions
Thu, 27 Feb 2025
Lucknow desk (R L Pandey).Best Extramural Institute Award to CSIR-CDRI by ICMR
CSIR_CDRI has received the excellence recognition in the Best Extramural Institute at the DHR_ICMR Health Research Excellence Summit 2024, held on Nov 14 as part of @ICMRDELHI's 113th Foundation Day celebrations.
Smt. Anupriya Patel, Hon'ble Union Minister of State in the Ministry of Health & Family Welfare presided over the meeting. The award recognizes the impactful publications and innovative advancements in health research made by the scientists of the Institute.
Excellence for Women in STEM Award by CII
CSIR-CDRI, Lucknow received the Confederation of Indian Industry (CII's) Excellence for women in STEM Award at a ceremony presided over by Dr. V. K Saraswat, Member NITI Aayog, Dr. Akhilesh Gupta, Former Secretary, SERB &, Senior Advisor Department of Science and Technology, Government of India & Dr Brajesh Pandey, Executive Director,
Indian National Science Academy -INSA graced the occasion.
CSIR-Central Drug Research Institute Lucknow and Zydus Lifesciences Ltd, Ahmedabad came together to develop best-in-class drug for Chronic Kidney Disease induced Osteoporosis
Based on research conducted at CDRI and data from antibody-based therapies (biologics), Sclerostin has emerged as a promising drug target for treating CKD-induced osteoporosis as well as postmenopausal osteoporosis. Studies suggest that the protein Sclerostin plays a key role in the dysregulation of bone metabolism. In patients with advanced stages of CKD and osteoporosis, Sclerostin levels are observed to be high. To develop oral medication through the discovery of small molecule inhibitors of Sclerostin, a collaborative research agreement was signed by Zydus Lifesciences Ltd, Ahmedabad and Central Drug Research Institute, Lucknow at Zydus Research Centre, Ahmedabad. Under this agreement, CDRI and Zydus will jointly undertake preclinical research. Any drug candidate emerging from the efforts will be developed by Zydus for India and other markets.
CSIR-CDRI and CHINTA Kolkata singed an MoU to Develop Brain Organoids for Alzheimer’s Research
An MoU was signed with the Centre for High Impact Neuroscience and Translational Applications (CHINTA), Kolkata, to jointly develop Alzheimer’s disease-specific Brain Organoids for research and therapy. The agreement was formalized by Professor Sumantra Shona Chattarji, Director, CHINTA; Dr. Radha Rangarajan, Director, CSIR-CDRI; Dr. P.N. Yadav, Head of Neuroscience, CSIR-CDRI.
CSIR-CDRI Transferred technology to MyLab Discovery Solutions, Pune to develop first indigenous multiplexed detection kit for Dengue (DEN), Chikungunya (CHIK), and Zika (ZIK) viruses.
Additionally, CSIR-CDRI successfully transferred the technology for an indigenous RT-PCR kit to MyLab Discovery Solutions, Pune. This is the first indigenous multiplexed detection kit for Dengue (DEN), Chikungunya (CHIK), and Zika (ZIK) viruses, offering high sensitivity and specificity for rapid, accurate, and simultaneous diagnosis of arboviral infections with overlapping symptoms such as fever, joint pain, muscle pain, and rashes. The kit features indigenously developed RT-PCR probes, promoting self-reliance under the Atmanirbhar Bharat initiative.
*Faculty Achievements*
• Dr Namrata Rastogi received Bronze Medal Award-2024 by the Chrantan Rasayan Sanstha
• Dr Damodar Reddy Young Scientist Award-2025 by Indian Peptide Society
• Dr S.K. Rath was elected as Fellow of Society of Toxicology
• Dr Aamir Nazir was elected as Fellow of Indian Academy of Neurosciences
• Dr Satish Mishra was elected as Fellow of the National Academy of Biological Sciences